clenziderm m.d. system

Product NDC: 62032-613
11-digit product format: 620320613
Labeler code: 62032
Product ID: 62032-613_bab0a250-f922-44f7-bd9e-517ebeb25fa7
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID AND BENZOYL PEROXIDE
Dosage form: KIT
Labeler: Obagi Cosmeceuticals LLC
Application: M006
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2012-01-01
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	62032-613	62032-613-01	D	Discontinued by firm		2026-10-05
excluded package	package	62032-613	62032-613-15	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 34 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-613-15	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-613-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-613-15	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-613-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-613-15	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-613-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-613-15	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-613-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-613-09	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-613-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-613-15	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-613-09	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-613-01	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-613-15	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-613-09	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-613-01	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-613-15	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-613-09	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-613-01	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-613-15	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-613-09	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-613-01	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-613-15	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-613-01	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-613-15	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-613-01	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-613-15	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-613-01	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-613-15	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: clenziderm m.d. system
Brand name suffix: acne therapeutic system
Listing expiration: 2026-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 7 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
106309	Internal RxNorm lookup
251577	Internal RxNorm lookup
562600	Internal RxNorm lookup
1235205	Internal RxNorm lookup
1235208	Internal RxNorm lookup
1236624	Internal RxNorm lookup
2191891	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7710e51a-dd3a-4f44-8c97-c089c6817cb0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d9d61457-6a5a-41fc-b418-e5479a2904b7	Product name	2	20230303
32012d5c-25ac-49c7-9d4c-1313177fff7c	Product name	1	20230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
3f45980c-c196-47e5-0e5e-48b7c57327c5	Product name	5	20200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
62032-613-01	2025-03-19	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-09	2025-03-19	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-15	2025-03-19	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-01	2025-01-30	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-09	2025-01-30	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-15	2025-01-30	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-610-11	clenziderm m.d. systemacne therapeutic system	118 mL in 1 BOTTLE, PLASTIC	LIQUID	118 mL	20 mg in 1mL	3
62032-611-01	clenziderm m.d. systemacne therapeutic system	47 mL in 1 BOTTLE, PLASTIC	LOTION	47 mL	50 mg in 1mL	3
62032-612-04	clenziderm m.d. systemacne therapeutic system	148 mL in 1 BOTTLE, PLASTIC	LIQUID	148 mL	20 mg in 1mL	3
62032-613-01	clenziderm m.d. systemacne therapeutic system	1 in 1 CARTON	KIT	1		3
62032-613-09	clenziderm m.d. systemacne therapeutic system	1 in 1 CARTON	KIT	1		3
62032-613-15	clenziderm m.d. systemacne therapeutic system	1 in 1 CARTON	KIT	1		3
62032-613-15	clenziderm m.d. systemacne therapeutic system	1 in 1 BAG	KIT	1		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-613	CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OBAGI COSMECEUTICALS LLC]	3	Current NDC, Legacy NDC, 7 package rows	20250322_7710e51a-dd3a-4f44-8c97-c089c6817cb0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 56 · 1,101 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GlowBiotic Probiotic Acne Cleanser	SALICYLIC ACID	Glowbiotics	546334bf-cf47-a1e5-e063-6394a90a590c	2026-06-16	Warnings	Exact identifier application number: M006
La Roche Posay Laboratoire Dermatologique Effaclar Duo Plus M MultiTarget Acne Treatment	SALICYLIC ACID	L'Oreal USA Products Inc	5464d48b-495c-e45f-e063-6394a90aedfc	2026-06-16	Warnings	Exact identifier application number: M006
La Roche Posay Laboratoire Dermatologique Effaclar Duo Plus M MultiTarget Acne Treatment	SALICYLIC ACID	COSMETIQUE ACTIVE PRODUCTION	54650326-1582-26b7-e063-6394a90a575c	2026-06-16	Warnings	Exact identifier application number: M006
Butterflys tear MILIA REMOVER	SALICYLIC ACID 1% MILIA REMOVER	Jiangxi Yudexi Pharmaceutical Co., LTD	52226dfd-eafa-42d7-e063-6394a90a16ef	2026-06-12	Warnings	Exact identifier application number: M006
Proven Acne Cleanser	SALICYLIC ACID	Proven Skincare	316702b8-4f9d-0a42-e063-6394a90ad8e1	2026-06-11	Warnings	Exact identifier application number: M006
Proven Acne Cleanser	SALICYLIC ACID	Proven Skincare	31a29bdd-a218-247a-e063-6294a90a8cee	2026-06-11	Warnings	Exact identifier application number: M006
Clopoat CLOPOAT ACNE-CLEARING SPOT	COLLOIDAL SULFUR	Guangzhou Meixi Biotechnology Co., Ltd.	53cd1d6b-d44c-2508-e063-6294a90a96c6	2026-06-09	Warnings	Exact identifier application number: M006
Good Molecules Acne Foaming Cleanser	SALICYLIC ACID	Twincraft Inc.	4911ef14-b465-3398-e063-6394a90a9c9a	2026-06-09	Warnings	Exact identifier application number: M006
PanOxyl Pore Refining Acne Mask	SULFUR	Crown Laboratories, Inc.	5373574c-95be-dd88-e063-6394a90ae519	2026-06-05	Warnings	Exact identifier application number: M006
Acne Control Serum	BENZOYL PEROXIDE	Private Label Skin Care	d4a4b89f-c9cf-4188-9c61-e8ef22b7638c	2026-06-03	Warnings	Exact identifier application number: M006
BellamiLuxx Body acne cleanser	BENZOYL PEROXIDE 4%	BellamiLuxx LLC	532baae0-7e6f-1764-e063-6394a90a11ce	2026-06-01	Warnings	Exact identifier application number: M006
Clean and Clear Acne Spot Treatment	SALICYLIC ACID	Kenvue Brands LLC	532c48d7-6d7b-ba96-e063-6394a90a9c30	2026-06-01	Warnings	Exact identifier application number: M006
SkinCeuticals Blemish Plus Age Defense Acne Treatment	SALICYLIC ACID	LOreal USA Products Inc	727fa830-1f71-40ae-8153-7a29dbcb5e29	2026-06-01	Warnings	Exact identifier application number: M006
Hero Pore Release Blackhead Clearing	SALICYLIC ACID	Church & Dwight Co., Inc.	436cf03c-3f74-4a02-bb0a-1d24f5c4fc29	2026-06-01	Warnings	Exact identifier application number: M006
Principal Secret Blemish Buster Clear	SALICYLIC ACID	Guthy-Renker LLC	75387738-eca2-4184-833b-95005eb27666	2026-05-29	Warnings	Exact identifier application number: M006
KUGIG ACNE TREATMENT SPRAYER	SALICYLIC ACID	Guangdong Jiaoyu Biotechnology Co., Ltd.	52b1e9cb-c083-a6eb-e063-6294a90ab6d1	2026-05-26	Warnings	Exact identifier application number: M006
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE BENZOYL PEROXIDE EFFACLAR BPO	BENZOYL PEROXIDE	LOreal USA Products Inc	851882ac-56f4-4bf6-b942-6efea10eec3e	2026-05-26	Warnings	Exact identifier application number: M006
BLEMISH DOTS - RETINOL (10 PATCHES)	SALICYLIC ACID 0.5%	MELON BIO-TECH (THAILAND) CO., LTD.	201eeecd-e759-42b8-b5c2-b19465d98332	2026-05-25	Warnings	Exact identifier application number: M006
BLEMISH DOTS - CHARCOAL (10 PATCHES)	SALICYLIC ACID 0.5%	MELON BIO-TECH (THAILAND) CO., LTD.	a5431ecd-0afc-4525-9157-ee05ff752df5	2026-05-25	Warnings	Exact identifier application number: M006
XEXLVOV MILIA REMOVER	SALICYLIC ACID 1% MILIA REMOVER LIQUID	Shanghai Honghui Chuang Intelligent Technology Co., Ltd	529bf32f-b40b-9602-e063-6294a90a1c2a	2026-05-24	Warnings	Exact identifier application number: M006

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2191891	{1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	GPCK	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
106309	benzoyl peroxide 5 % Topical Lotion	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	Clenziderm Lotion 5 % Topical Lotion	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	CLENZIderm M.D. 2 % Medicated Liquid Soap	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Medicated Liquid Soap	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
251577	salicylic acid 2 % Topical Solution	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
2191891	salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion]	SBD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm]	SBD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
106309	benzoyl peroxide 50 MG/ML Topical Lotion	SCD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 20 MG/ML Medicated Liquid Soap	SCD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
251577	salicylic acid 20 MG/ML Topical Solution	SCD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
106309	benzoyl peroxide 5 % Topical Lotion	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	Clenziderm 20 MG/ML Medicated Liquid Soap	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	Clenziderm 20 MG/ML Topical Solution	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	Clenziderm Lotion 5 % Topical Lotion	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	Clenziderm Lotion 50 MG/ML Topical Lotion	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	Clenziderm M.D. 2 % Daily Care Cleanser	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	Clenziderm M.D. 2 % Pore Therapy	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Facial Cleanser Toner	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Facial Scrub	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Medicated Liquid Soap	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
251577	salicylic acid 2 % Topical Solution	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
2191891	salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62032-610-11	62032061011	118 mL in 1 BOTTLE, PLASTIC	118 ml					Historical
62032-611-01	62032061101	47 mL in 1 BOTTLE, PLASTIC	47 ml					Historical
62032-612-04	62032061204	148 mL in 1 BOTTLE, PLASTIC	148 ml					Historical
62032-613-01	62032061301	1 KIT in 1 CARTON (62032-613-01) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-04)	1 kit	2012-01-01	0000-00-00	No	No	Current
62032-613-09	62032061309	1 KIT in 1 CARTON (62032-613-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)	1 kit	2021-11-01	0000-00-00	No	No	Current
62032-613-15	62032061315	1 BAG in 1 CARTON (62032-613-15) > 1 KIT in 1 BAG * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)	1 bag	2012-11-01	2022-12-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC	2025-03-19	HUMAN OTC DRUG LABEL	3